Skip to search formSkip to main contentSkip to account menu

olamufloxacin

Known as: (-)-5-Amino-7-((S)-7-Amino-5-Azaspiro(2,4)Hept-5-yl)-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-8-Methyl-4-Oxo-3-Quinolinecarboxylic Acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Fluoroquinolones

Narrower (1)

HSR-903

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
In vitro Antibacterial Activities of New Fluoroquinolones against Clinical Isolates of Haemophilus influenzae with Ciprofloxacin-Resistance-Associated Alterations in GyrA and ParC
Background: The in vitro antimicrobial activities of new fluoroquinolones were tested against quinolone-resistant Haemophilus… 
2003
2003
Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.
OBJECTIVES To determine the susceptibility of southern African strains of Yersinia pestis to novel as well as conventional… 
2003
2003
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in vitro and in vivo. The… 
2001
2001
The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice.
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin… 
Review
2000
Review
2000
Olamufloxacin. Hokuriku Seiyaku.
Hokuriku is developing olamufloxacin, a quinolone antibiotic that inhibits DNA gyrase, for the potential treatment of various… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)